Introduction
The ghrelin receptor is aGprotein-coupled receptor with a basal activity of 50 %o ft he signaling induced by its endogenous ligand ghrelin. [1] Due to this ligand-independenta ctivity, the receptor can be targeted by two differentk ind of ligands: agonists can further increase the activity, and inverse agonists decreaseb asal activity. [2] As the receptor plays am ajor role in energy homeostasis, growth hormone release and alcohol abuse, it is an interesting therapeutic target. [3] However,s ubstantialk nowledge of the interaction between the receptor and ligand is still missing, which would allow the design of specific ligands andt od ecrease the side effects of therapeutics.
The interaction between ghrelin and its receptor was investigated in detail in the last few years. Ghrelin(1-4) is necessary for receptor activation, although binding affinity is two orders of magnitude lower than that of full-length ghrelin. [4] It is assumed that the Ser 3 lipidation with octanoic acid is important for membranei nteraction. [5] In as tructuralm odel of ghrelin boundt oi ts receptor,i tw as proposed to extend this minimal binding motif up to His 9 . [6] Therein, amino acids 1t o5a nd His 9 and Arg 11 directly interactw ith the receptor.T he N-terminal motif binds with the centralc avity in the ghrelinr eceptor,a nd the a-helix with His 9 interacts with ECL3. Phe 4 is close to glutamine in transmembrane helix three (Gln120 3.29 )a nd isoleucine in helix four (Ile178 4.60 ).
Constitutive activity of the ghrelinr eceptor is based on the presence of aromatic locks in the receptor.P he279 6.51 , Phe309 7.39 ,a nd Phe312 7.42 form an aromatic clustert hat was described to be crucial by Holst et al. in 2004 . [1a] Furthermore, Trp276 6.48 of the CWxP motif plays an important role in constitutive activity and interacts with Phe221 5.47 to stabilizea ctive conformations. [7] Moreover,H is280 6.52 is also thought to be relevant in constitutive activity by interacting with the two amino acids and Arg283 6.55 . [8] The hexapeptideK wFwLL-NH 2 binds with its N-terminus deep in the receptor binding pocket; d-Trp 2 is located close to the aromatic phenylalanine clustera nd can disrupt this interaction. [9] Substitutiono fd-tryptophan by the slightly bulkier1 -naphthyl and 3-benzothienyl functionalities resulted in increased activity and decreased constitutive activity.I nc ontrast, agonism can be induced by exchanging dtryptophan at position 4w ith d-2-naphthylalanine. [10] KwFwLL-NH 2 is remarkably sensitivet os malls tructural changes,a nd Phe 4 of ghrelin is important for receptor interaction. [6, 10, 11] Thus, we introduce ap airo fd iastereomeric bphenyl tryptophans as shown in Figure 1i nt hese two peptides. Synthetic methods for the construction of enantiopure b,b-diaryla mino acids have advanced in the past couple of years and are becoming increasingly relevant in the modification of peptides. [12] The side chains of phenylalaninea nd tryptophanw ere combinedt oo btain Wrf and Wsf. The analogues
We describe two synthetic amino acids with inverteds ide chain stereochemistry,w hich induce opposite biological activity.P he 4 is an importantp art of the activation motif of ghrelin, and in short peptidei nverse agonists such as KwFwLL-NH 2 ,t he aromatic core is necessary for inactivation of the receptor.T o restricti ndole/phenylm obility and simultaneously strengthen the interaction between peptide and receptor,w eexchanged the natural monoaryl amino acids for diaryl amino acids derived from tryptophan. By standard solid-phase peptides yn-thesis, each of them was inserted into ghrelin or in the aromatic core of the inverse agonist.B oth ghrelina naloguess howed nanomolar activity,i ndicating sufficient space to accommodate the additional side chain. In contrast, diaryl amino acids in the inverse agonist had considerable influence on receptor signaling. Whereas the introduction of Wsf maintains inverse agonism of the peptide, Wrf shifts the receptor more to active states and can induce agonismd epending on its introduction site.
were synthesized using CH activation and introducedi nt he peptideb ys olid-phasep eptides ynthesis. Interestingly,t hese space-demanding sidec hains affect activity when introduced at peptide positions important forr eceptor interaction only slightly in ghrelin analogues, but significant effects were found for the signaling of the small inverse agonist.
Results and Discussion
Synthesis and analysis of diaryl amino acids with naturally occurring side chains Wrf and Wsf wereo btained by Cb arylation of adequately protected Phe and Trpp recursors, respectively.F or Wrf, l-Phew as N-terminally protected with ap hthaloyl (Phth)g roup, C-terminally modified with 8-aminoquinoline (8AQ) and sidec hain protected with tert-butyloxycarbonyl (Boc). The crucial synthetic step wast he CÀCb ond formation that requires ad irecting group like 8AQ to form the palladium complex necessary for diastereoselectiveC b arylation. [13] The diastereoselective b-indoylation of racemic Phth-Phe-8AQ gave rac-Phth-Wrf/wsf-8AQ, whichw as crystallized and examined with X-ray analysis ( Figure 2 ).
The asymmetricc ell contains both enantiomers with an antiperiplanar arrangemento fH a and Hb that minimizes steric strain aroundt he CaÀCb bond. Consequently,t he Phe moiety of Phth-Wrf(Boc)-8AQ (1)a ssumesac1a ngle of À41.48,w hile the Trpmoiety is found to be À163.88.The indolyl group is oriented with c2 = 39.78.
In solution, the indolyl group of Phth-Wrf(Boc)-8AQ assumes an analogous orientation as in the crystal as determined from NOEs and 3 J coupling constants as showni nF igure 3. In spite of the congested environment, the phenylr ing shows the AMM'XX' spin system expected for am obile aromatic ring with al ow barrier of rotation about the CbÀCg bond of the phenyl ring. H2 of the indole moiety is oriented towardH a in Phth-Wrf(Boc)-8AQ and Phth-Wsf(Boc)-8AQ (2), resultingi na"mirrored" presentation of important motivef or receptor interaction.
The phenylation of Phth-Trp(Boc)-8AQ yieldedP hth-Wsf(Boc)-8AQ. The c1r otation of Ha and Hb is antiperiplanar like the diastereomer Phth-Wrf(Boc)-8AQ. The orientation of the Phe moietyi sa ntiperiplanar with respect to the highest priority substituent (NPhth), whereas the Trpmoiety is oriented gauche minus with a c2a ngle of about 1208 of the indole ring. In conclusion, the conformational analysiss hows that the indolyl moiety assumes a" mirrored" orientation in Wsf relative to Wrf,w hich resultsi na no pposite presentation of the important indole motif toward the receptor.T he conformation of both building blocks is best visualizedb yt he Newman projections of the amino acids. The c2r otation is fixed for the Trp moiety while Phe shows high rotational mobility forb oth amino acids. The effect for Phe is similart ot he so-called "steric gearing", which is well studied for two 6-p-aromatic rings linked to the same carbon whereing round state destabiliza- tion causedb yt he close proximity of the two rings lowers the rotational barrierins pite of the steric crowding. [14] The CH arylation of enantiopure amino acids followed by protecting group manipulations [13] yielded Fmoc-Wrf(Boc)-OH (3)a nd Fmoc-Wsf(Boc)-OH (4), which were then used in solidphase peptide synthesis for the assembly of the ghrelina nalogues.
Incorporation into peptides by solid-phase peptide synthesis
The diaryl amino acids were introduced in the peptide backbone. We chose ghrelin (5)a nd the ghrelin receptor inverse agonistK wFwLL-NH 2 (8)a sb othp eptides contain Phe and Trp that are important for receptor activity.P he 4 in ghrelin and either d-Trp 2 ,P he 3 or d-Trp 4 in the inverse agonist weres ubstituted by Wrf or Wsf. The diaryl amino acids were coupled by standards olid-phase peptides ynthesis. Exemplarily,t his is shownw ith analytics for Wsf 4 -ghrelin( 7)i nF igure 4.
We have successfully incorporated the diaryl amino acids in the sequence. After automated synthesis of ghrelin(5-28), Wsf was coupledw ith DIC and HOBt. To decrease the amount of building block, reactionw as carriedo ut twice with 0.5 equiv for 4h and 1equiv overnight, respectively.M Sa nd RP-HPLC analysis of intermediates showed high coupling efficiency,a nd as hift in hydrophobicity could be observed in RP-HPLC following Wsf coupling. The same has been found for the Wrf analogue.A fter N-terminal elongation and coupling of octanoic acid, the peptide was purified. Full cleavage of the peptide demonstrated high couplinge fficiencies for all amino acids. Followingp urification, all peptides were analyzed on two different RP-HPLC columns and by MALDI-ToF mass spectrometry. Purity of > 95 %a nd correct identity was observed for all compounds ( Table 1) .
In the past, b,b-modified amino acidsw ere included in the peptideb ackbone, as Dip (b,b-diphenyl alanine) at position2 in the short lead peptide. [10] However to our knowledge,n o peptides with stereoisomeric b,b-diaryla mino acids containing natural side chains were introduced into ap eptide before. Comparing the retention times of the lead peptides with diaryl amino acids analogues, it is notable that there are no clear changes in the retention time. It can be assumedt hat the additional phenyl or indole group does not influence the hydrophobicity of the peptides in ag reat extent. 
Introduction of diaryl amino acids had considerable influence on peptide behavior
All analogues were tested in an IP-One assay to evaluatet he activity of the analogues relative to the lead. COS7 cells stably transfected with the ghrelin receptor C-terminally tagged with eYFP were used and incubated with different ligand concentrations for 3h.G hrelin (5)h ad ap otency of 2.8 nm,w hich is in the range of previouss tudies. [10, 16] KwFwLL-NH 2 (8)a nd KbFwLL-NH 2 (b = 3-benzothienyl alanine, 15)w ere used as control and EC 50 values of 183 nm and 22.9 nm were observed, respectively.C ompared with radioactiveI Pa ccumulation assays, both peptides possessed an approximately 10-foldr educed activity in the Cisbio IP-One assay. [10] However,o ther groups that used the assay could obtain similarE C 50 values as found in this study for KwFwLL-NH 2 . [16] Wrf 4 -a nd Wsf 4 -ghrelin (6 and 7)b ehaved similar in the cell studies with ap otencyl oss of about 12-fold( Figure 5A ). However,e fficacy was similar to ghrelin( Table 2) . As position 4i s part of the minimal bindingm otif of ghrelint oi ts receptor, [6] it can be concluded that the binding pocket is not so narrow aroundP he 4 and there is space for an additional aromatic group as the peptide is still able to activate the receptor. Also the orientation seems to be not important as both analogues 6 and 7 show comparable activity.
VanC raenenbroeck et al. investigated Phe 4 by Ala and Tyr substitution in ghrelin(1-14) analogues. [17] While Ala 4 showed no activity in an IP accumulation assay and significantly reduced activity in Ca 2 + assay compared to ghrelin(1-14), this loss of activity and affinity could be restored partially by Tyr 4 . This underlines the importance of an aromatic group at this position. As Phe 4 is closet oG ln120 3.29 and Ile178 4.60 , [6] interactions may be based primarilyo nh ydrophobic interactions.
First generation of ghrelin inverse agonistp eptides containing diaryla mino acids were based on KwFwLL-NH 2 (8)a nd Wrf or Wsf were introduced into the aromatic core. To evaluate inverse agonism and agonism, the behavior and E max (decreased or enhanced receptor efficacy) of the peptide is of interest. However,t he efficacy was increased. Especially Wsf 2 (10) showedf ull inverse agoniste fficacy,t hat is, the peptidei sa ble to fully shift the receptor to the inactive state. Notably,W sf is still 18-fold less active than 15 with 3-benzothienyl side chain at position 2. Wrf 3 (11)a ctivates the receptors imilar to the lead peptidew ith decreased inverse agonist efficacy,a nd Wsf 3 (12)s howed an increasedi nverse agonist efficacy. The substitution of d-Trp 4 had am ore severe influencet han the other two positions. Whereas Wsf (14) i ntroductionr esulted in a more than 10-foldd ecreasei ni nverse agonista ctivity,W rf (13) completely diminishedt he inverse agonist effect. The peptide behavior was switched to agonismw ith low but detectable activity ( Figure 5B ). It is known from previouss tudies thatp osition 4c an be used to induce agonism characteristics into the peptide. [10] However,h ere the shift between agonism and inverse agonismi sb ased just on the configuration of the side chains of Wrf and Wsf. In general,W sf-containing peptides shift the receptor more to inactive states and Wrf to active states. Wsf peptides have higheri nverse agoniste fficaciesf or all monosubstituted analogues relative to the corresponding Wrf analogue. Interestingly,S AR studies of the inverse agonist [d-Arg 1 ,d-Phe 5 ,d-Trp 7, 9 ,Leu 11 ]-substance P, on which the short lead peptidei sb ased, demonstrated that the substitution of d-Trp 9 (same as d-Trp 4 in KwFwLL-NH 2 )w ith Ala and l-Trp completely diminished the inverse agonist activity. [18] This is in contrastt ot he findings in this study.H owever,t he additional phenyls ide chain may regain the lost activity.L eu 5 of KbFwLL-NH 2 was recently replaced by amino acids with variousc haracteristics and it was shown that Lys, Gln, Phe, and Ala can induce agonism. [11a] The most efficient agonistw as the d-2Nal 5 analogue, whereas 2Nal 5 had no activity at the ghrelin receptor.I nc ontrast, the introduction of either l-Trp or d-Trp at this positiond id not influence the peptideb ehavior,t he peptide remained an inverse agonist. This supports the idea that direction ando rientation of the aromatic side chains in short ghrelin peptides decide between agonism and inverse agonism. To further investigate the influenceo ft he diaryl amino acids, as econd generation of peptides was synthesized. The full inverse agonist KbFwLL-NH 2 (15)w as modified at position3w ith Wrf (16) o rWsf ( 17) . Whereas the combinationo fd-Bth and Wrf was similar to Kw-Wrf-wLL-NH 2 (11), introductiono fW sf significantly decreased the activity of the inverse agonist. Interestingly, similart ot he single modification of KwFwLL-NH 2 , there seems to be at endency that the Wsf-containing peptide is as tronger inverse agonist than the Wrf compound. In addition, Wrf 4 /Wsf 4 were studied in more detail.F or this, AwFn-Isn-NH 2 (n = d-2-naphthyl alanine, Isn = isonipecotic acid, 18)a nd KwFnLL-NH 2 (19) were used as comparison. We reported earlier that the short ghrelin ligands bind the receptor with its N-terminus facing into the binding pocket of the ghrelinr eceptor and it was proposed for KwFnLL-NH 2 (19)t hat Phe 3 and d-2Nal 4 can interact with each other. [9, 10] This interaction might be stronger for Wrf due to the restrictive relative orientation of its two aryl side chains. Therefore, the introduction into a known potent agonist was of interest. In IP-One assay,E C 50 valuesof16.4 nm and 228 nm were observed for 18 and 19,respectively.T he EC 50 value of 18 is similar to previous studies. [15] However, a1 0-fold shift has been observed for 19,s imilar to the inverse agonist. In addition, we observed super-agonism for 19 in ar adioactiveI Pa ccumulation assay but not in the Cisbio IPOne assays.W hen Wrf wasi ncluded into AwFn-Isn-NH 2 substituting d-2Nal (20), potency was almost the same as that of 18.T he corresponding Wsf analogue 21 had as lightly lower potencya nd efficacy than 20.
Interestingly,t he d-2Nal 4 analogue 19 was 4-fold more active than the Wrf 4 analogue (13), but the differences were diminished in the combined agonist. d-2Nal possesses strong agonism-prone characteristics at position 4a nd can even turn the efficient inverse agonist KbFwLL-NH 2 (15)i nto an agonist by substitution of Leu 5 . [11a] It is surprising that 20 can almost reach the same activity as 18.A dditionally,t he use of the stereoisomeric b,b-diaryl amino acids demonstrates that an additional aromatic group is not disturbing this interaction.
Conclusions
Understanding the binding and activation mechanism of G protein-coupled receptors is one of the most important tasks to facilitate drug development. We introduced stereoisomeric b,b-diaryla mino acids in the binding motif of ghrelin and the short ghrelin inverse agonistK wFwLL-NH 2 to evaluate the activation profile.D iaryl aminoa cids are ap owerful tool as they combine two side chains in different orientation and can help discussi nteraction patterns.H ere, we demonstrated that Phe 4ghrelin can be modified with Trp/Phe analogues and still possesses nanomolar activity and full efficacy.A dditionally,t he sensitivity of the aromatic core of as hort ghrelinr eceptor inverse agonist was confirmed and our studies displayt hat the orientation of the side chains in the stereoisomeric b,b-diaryl 
Experimental Section
Synthesis of b,b-diaryl amino acids Analysis of building blocks can be found in the Supporting Information. Protecting group manipulations were carried out as described previously. [13] Peptide synthesis Fmoc/tBu solid-phase peptide synthesis of ghrelin and the hexapeptides was performed on solid support with an automated multiple peptide synthesizer (SyroI, MultiSynTech, Bochum, Germany) and standard Fmoc-protected amino acids (Orpegen OPC, Heidelberg, Germany with af low rate of 0.6 mL min À1 to 1.55 mL min À1 was used depending on the column (l = 220 nm). Peptides were analyzed by MALDI-MS (UltraflexIII, Bruker,B remen, Germany). The observed masses were in full agreement with the calculated masses and peptides with ap urity ! 95 %c ould be obtained according to the analytical HPLC.
Cell culture and IP-One assay COS7 cells were stably transfected with the ghrelin receptor fused C-terminally to eYFP and cultured in ah umidified atmosphere at 37 8Ca nd 5% CO 2 in Dulbecco's modified Eagle'sm edium with higher glucose (Lonza, Basel, Switzerland) supplemented with 10 % (v/v)F CS (Biochrom, Berlin, Germany) and 0.4 mg mL À1 hygromycin B( Invivogen, To ulouse, France). For evaluation of the activity, Cisbio IP-One Gq assay kit was used according to previous description with alterations. [19] As tandard curve was prepared in HBSS with 10 mm LiCl to determine the linear range of the assay and to convert obtained HTRF ratio to IP1 concentrations. 10 000 cells per well were seeded out in a3 84-well flat white plate and cultured overnight. Stimulation was carried out in triplicates for 3h.P eptides were solved in DMSO and diluted with HBSS containing 10 mm LiCl (maximal DMSO content 1%). Subsequently,3mLI P1-d2 and 3 mLA b-cryptate in lysis buffer were added and incubated on at umbler for 60 min. Fluorescence was measured at 620 nm and 665 nm. HTRF ratio was calculated as the ratio 665/620. Obtained data were analyzed with GraphPad Prism 5.0 (GraphPad Software, San Diego, USA). Hexapeptide analogues with as ingle modification as well as inverse agonists were normalized to KbFwLL-NH 2 .G hrelin analogues and multiple substituted agonists were normalized to ghrelin for better comparison. E max is the efficacy of the peptide and represents the difference between constitutive activity and activity at maximal effect of the peptide. EC 50 is the peptide concentration at half-maximal effect.
